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It has come the publisher's attention that the original version of this article \[[@CR1]\] unfortunately contained an error. In Table 3, first column, the FcγRIIA 131 H\>R genotypes were incorrectly labelled. In particular, V/V should have read H/H, V/F should have read H/R and F/F should have read R/R. Please note that this correction does not change the genotype numerical values of FcγRIIA polymorphism. The correct Table 3 has been published as Table [1](#Tab1){ref-type="table"} in this Erratum.Table 1Genotypic and allelic frequencies of FcγRIIIA and FcγRIIA polymorphisms in breast cancer patients and healthy controlsGenotypes*n* (%)*P* ^*\**^Alleles*n* (frequency)*P°*NEO (*n* = 15)MTS (*n* = 10)CTR (*n* = 33)NEO (2*n* = 30)MTS (2*n* = 20)CTR (2*n* = 66)FcγRIIIA 158V\>FFcγRIIIA 158V\>F V/V4 (26.7)3 (30.0)6 (18.2)0.741 V13 (0.43)8 (0.40)26 (0.39)0.934 V/F5 (33.3)2 (20.0)14 (42.4) F17 (0.57)12 (0.60)40 (0.60) F/F6 (40.0)5 (50.0)13 (39.4)* HWEP* = *0.213P* = *0.065P* = *0.522*FcγRIIA 131H\>RFcγRIIA 131H\>R H/H3 (20.0)4 (40.0)9 (27.3)0.499 H14 (0.47)10 (0.50)35 (0.53)0.843 H/R8 (53.3)2 (20.0)17 (51.5) R16 (0.53)10 (0.50)31 (0.47) R/R4 (26.7)4 (40.0)7 (21.2)* HWEP* =* 0.782P* =* 0.058P *= *0.845*Genotyping of FcγRIIIA 158V\>F was performed by a newly developed PSQ method after pre-amplification of FcγRIIIA gene. Genotyping of FcγRIIA 131H\>R was performed by T-ARMS PCR and SBT. Conventionally, the 158V\>F variant corresponds to the G\>T SNP \[i.e. guanine corresponding to valine (V) and thymine corresponding to phenylalanine (F)\] and the 131H\>R SNP corresponds to the A\>G SNP \[i.e. adenine corresponding to histidine (H) and guanine corresponding to arginine (R)\]Comparison of FcγR genotypic and allelic frequencies between patients and control subjects was estimated using the Pearson's χ^2^ test (*P*\* value) and the Fisher's test (*P*° value), respectively. Statistical significance: *P* \< 0.05*NEO* neoadjuvant, *MTS* metastatic, *CTR* controls, *HWE* Hardy--Weinberg equilibrium. HWE was tested by the Pearson's χ^2^ test (*P* \< 0.05 indicates lack of HWE)

The online version of the original article can be found under doi:10.1186/s12967-015-0680-0.
